Navigation Links
Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
Date:5/17/2010

8.6 million on March 31, 2010, compared to $8.6 million on December 31, 2009. Accounts receivable balance was approximately $20.8 million on March 31, 2010, versus approximately $19.8 million on December 31, 2009. Days sales outstanding (DSO) were at 149 days. The Company had a current ratio of 5.7 to 1 and stockholders' equity of $43.4 million, with total assets of $48.9 million versus total liabilities of $5.6 million on March 31, 2010.

For the first three months of 2010, the Company generated $0.6 million in cash from operations versus $0.06 million used in operations reported for the same period in 2009.

Business Developments

As of March 31, 2010, Biostar has expended its rural supply network to approximately 6,000 sales outlets.

On April 27, Biostar addressed and resolved a concern that its main product, Xin Aoxing, was to be suspended from selling by the local State Food and Drug Administration (SFDA) due to non-compliance with approved advertising use.

On April 23, 2010, Biostar was approved by NASDAQ to list its common stock on the NASDAQ Global Market and commenced trading under the ticker symbol BSPM.

On April 12, 2010, Biostar completed Chinese Military Drug Administration clinical trials for Zushima Analgesic Aerosol Spray ("Zus
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
2. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
3. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
4. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
7. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
8. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
9. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
10. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
11. Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... field of molecular electronics could take our definition ... construction of tiny circuits from molecular components. In ... on the roles currently played by comparatively-bulky wires, ... from five Japanese and Taiwanese universities has identified ... a molecule called picene. In a paper published ...
(Date:9/16/2014)... September 16, 2014 BlueInGreen® ... most efficient method for delivering dissolved gases into ... Inc. as a manufacturer’s representative firm to ... dissolution products for municipal water and wastewater applications ... , H2Flow was founded in 1992 and serves ...
(Date:9/16/2014)... CIRTEC Medical Systems’ Board of Directors has ... CIRTEC. , “I am delighted to be joining ... Brian Highley. “The company has made great strides improving ... over the past two years. The goal now is ... expand the services Cirtec offers its medical device customers.” ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... initiatives to position themselves for their 89th ... labeling and encoding, Pharma Packaging Solutions is ... hardware and software and new procedures. Establishing ... Good Manufacturing Practices (cGMP), Pharma Packaging Solutions ...
Breaking Biology Technology:The future face of molecular electronics 2BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2
... STAAR Surgical Company (Nasdaq: STAA ), a ... products, today announced that it has received CE Mark ... use in minimally invasive cataract surgical procedures. The ... intraocular (IOL) KS-X lens delivery system in the European ...
... ... Matrix Genomics, Inc. have identified a concise genetic signature found among a third of Parkinson,s ... is found in the LRRK2 gene located on chromosome 12. The work was led by ... ...
... Bioscience International, a leader in enabling and accelerating the ... China, today announced a strategic drug co-development partnership with ... range of therapeutic areas and represents one of the ... biotech company and a Chinese university. , , ...
Cached Biology Technology:STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System 2STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System 3STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System 4Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease 2Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease 3HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 2HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 3
(Date:9/15/2014)... is a vital source of energy for both plants ... its way into the cell could lead to the ... increase in the amount of fruits and vegetables farmers ... uncovered one of these "pathways" into the cell by ... a strand of spider silk. , To determine the ...
(Date:9/15/2014)... State University researchers have found "the most famous wheat ... be used to transfer valuable genes from ... for breeders to develop wheat varieties with the disease- ... of genetic tools that can reduce crop losses and ... controversy of Genetically Modified Organisms, or GMOs., "The real ...
(Date:9/15/2014)... strategic vision document, released today by the National ... long-term goals, objectives, and strategies for the program ... the next five years (2015-2020). In addition, ... to be funded in 2015, will include exploratory ... , The $500 million, 30-year program to ...
Breaking Biology News(10 mins):X-rays unlock a protein's SWEET side 2X-rays unlock a protein's SWEET side 3WSU researchers find 'most famous wheat gene' 2NAS Gulf Research Program announces strategic vision, initial opportunities 2NAS Gulf Research Program announces strategic vision, initial opportunities 3NAS Gulf Research Program announces strategic vision, initial opportunities 4
... NEW YORK, April 5, 2010 Alpha cells in ... insulin-producing beta cells, advancing the prospect of regenerating beta cells ... come from a study at the University of Geneva, co-funded ... in the online edition of the scientific journal Nature ...
... always get what they want, to paraphrase the Rolling Stones, ... a study that will appear in the May issue of ... both the broad sweep of evolutionary changes in life on ... regional environmental shifts. And yet the amount of variability seen ...
... Commission has approved a $1,127,873 award to Yellow ... of Cincinnati for their "Advanced Modified Carbon Nanotube-Based ... Research Professor William Heineman, in the McMicken College ... officially part of the million-dollar team. ...
Cached Biology News:Researchers show some cells in pancreas can spontaneously change into insulin-producing cells 2Researchers show some cells in pancreas can spontaneously change into insulin-producing cells 3Ecologists receive mixed news from fossil record 2Ohio Third Frontier awards million-dollar grant to YSI-University of Cincinnati team 2Ohio Third Frontier awards million-dollar grant to YSI-University of Cincinnati team 3
... yeast/leuconostoc overproducer ATP: D-hexose 6- ... One unit of HK will ... in 1 min at 25C ... of G6P-DH will oxidize 1 ...
... coli strain containing an overproducing clone of T4 ... formation of a phosphodiester bond between juxtaposed ... or RNA. It repairs single-stranded nicks in duplex ... both blunt-end and cohesive-end fragments of duplex DNA ...
... product is expected to react with ... but has not been specifically determined. ... line against partially purified rabbit muscle ... with all forms of Pyruvate kinase. ...
... component of the COP9 signalosome complex (CSN), ... developmental processes. The CSN complex is an ... pathway by mediating the deneddylation of the ... The complex is also involved in phosphorylation ...
Biology Products: